PCOS Skin and Hair Symptoms Explained

REVIEWED BY

William Maish, MD MBA MPH

Clinical Product Lead

Published

Last updated

Key takeaway:

PCOS skin and hair symptoms are driven by androgen excess — testosterone converted to the more potent DHT by 5-alpha reductase — thinning scalp hair while stimulating facial and body hair. Elevated insulin suppresses SHBG, freeing testosterone to reach skin and sebaceous glands. Testing free testosterone, SHBG, DHEA-S, and fasting insulin surfaces the dominant driver.

Read more →

Understand what your PCOS results really mean

See your biomarkers in context with a comprehensive panel.

  • CLIA-certified labs
  • HIPAA compliant
  • Personalized health protocol
Book your test

You're dealing with acne that won't clear, hair thinning on top of your head, or dark coarse hair growing where it shouldn't. Your dermatologist treats the surface, but the root cause is hormonal. PCOS drives skin and hair symptoms through specific pathways that topical treatments alone can't fix.

What PCOS does to androgens and insulin

Polycystic ovary syndrome disrupts two major systems: androgen production and insulin signaling. In PCOS, the ovaries produce excess androgens, primarily testosterone and androstenedione. High levels of luteinizing hormone (LH) and insulin both stimulate the ovaries to make more of these hormones. At the same time, many women with PCOS develop insulin resistance, meaning cells don't respond efficiently to insulin, so the pancreas compensates by producing more.

This creates a feedback loop. Elevated insulin prevents the liver from making sex hormone-binding globulin (SHBG), a protein that binds to testosterone and keeps it inactive. With less SHBG, more testosterone circulates freely in the blood. Free testosterone is biologically active. It binds to androgen receptors in the skin, hair follicles, and sebaceous glands, triggering the visible changes that define the PCOS face and scalp.

Testosterone itself isn't the only player. Inside certain tissues, an enzyme called 5-alpha reductase converts testosterone into dihydrotestosterone (DHT), a much more potent androgen. DHT binds tightly to androgen receptors in hair follicles and oil glands, driving both hair miniaturization on the scalp and increased sebum production in the skin. This dual action explains why the same hormonal imbalance can cause hair loss on your head and excess hair growth on your face.

How androgen excess affects skin, hair follicles, and oil glands

Sebaceous glands and acne formation

In sebaceous glands, elevated androgens increase oil production, creating an environment where acne-causing bacteria thrive. The result is inflammatory acne, often cystic, concentrated along the jawline, chin, and lower cheeks. This distribution pattern reflects where androgen receptors are most concentrated.

Scalp follicles and hair loss

Scalp follicles, particularly at the crown and temples, are sensitive to DHT. When DHT binds to receptors in these follicles, it shortens the growth phase of the hair cycle and shrinks the follicle itself. Over time, thick terminal hairs become fine vellus hairs, leading to androgenic alopecia, or female pattern hair loss.

Facial and body hair growth

Hair follicles on the face, chest, abdomen, and back respond to androgens by converting vellus hairs into thicker, darker terminal hairs, a condition called hirsutism. The same androgen excess that thins hair on your scalp stimulates growth in areas where men typically have hair.

Join 150,000+ others building better health

Get the science behind better health, every week.

By clicking “Subscribe” you agree to our Terms of Service and Privacy Policy.

Why insulin resistance darkens and tags the skin

When insulin levels stay chronically elevated, the hormone begins to interact with insulin-like growth factor (IGF-1) receptors in the skin. This triggers keratinocytes and fibroblasts to proliferate, thickening the skin and increasing pigmentation. The result is acanthosis nigricans, velvety, hyperpigmented patches that typically appear in body folds: the back of the neck, armpits, groin, and under the breasts.

Acanthosis nigricans isn't dirt, and it doesn't scrub off. It's a visible marker of what's happening metabolically. The darkened skin reflects insulin's effect on skin cell turnover and melanin production. In PCOS, this is often one of the earliest signs of insulin resistance, appearing before blood sugar levels become overtly abnormal.

Skin tags, small benign growths that protrude from the skin surface, also correlate with insulin resistance. They tend to cluster in the same areas as acanthosis nigricans. While the exact mechanism isn't fully understood, skin tags are associated with hyperinsulinemia and metabolic syndrome. Their presence suggests that insulin signaling is disrupted enough to affect skin cell behavior, making them a useful clinical clue even without lab work.

What drives androgen levels and insulin sensitivity

Androgen excess in PCOS has multiple origins. The primary driver is ovarian androgen production, stimulated by elevated LH and insulin. But adrenal androgens, particularly DHEA-S (dehydroepiandrosterone sulfate), also contribute in some women. If DHEA-S levels are significantly elevated, it suggests the adrenal glands are part of the picture, not just the ovaries.

Insulin resistance is influenced by genetics, body composition, diet, and physical activity. Visceral fat, the fat stored around internal organs, is metabolically active and worsens insulin resistance. It releases inflammatory cytokines and free fatty acids that interfere with insulin signaling.

High intake of refined carbohydrates and added sugars spikes blood glucose and insulin repeatedly throughout the day, keeping insulin levels chronically elevated. Over time, cells become less responsive to insulin's signal, requiring even more insulin to achieve the same effect. Physical activity, particularly resistance training and high-intensity interval training, improves insulin sensitivity by increasing glucose uptake into muscle cells independent of insulin.

Chronic stress elevates cortisol, which raises blood sugar and promotes visceral fat accumulation. Sleep deprivation disrupts glucose metabolism and increases insulin resistance. Both factors worsen the hormonal environment that drives PCOS skin and hair symptoms.

Test 150+ biomarkers

Two blood draws. A full picture of your health, explained in plain language.

Book your test

Why the same diagnosis produces different skin and hair patterns

Not every woman with PCOS experiences the same symptoms. Some have severe acne but no hair loss. Others lose hair rapidly but have clear skin. The difference lies in individual androgen sensitivity, enzyme activity, and the balance between ovarian and adrenal androgen production.

Genetic variation in androgen receptor genes affects how strongly tissues respond to circulating androgens. Two women with identical testosterone levels can have vastly different symptoms if one has more sensitive androgen receptors. Similarly, variation in 5-alpha reductase activity determines how much testosterone gets converted to DHT locally in the skin and scalp. Higher enzyme activity means more DHT, which translates to more severe acne and hair loss.

The ratio of ovarian to adrenal androgens also varies. Women with predominantly ovarian androgen excess often respond well to treatments that suppress ovarian function, like combined oral contraceptives. Those with elevated DHEA-S may need interventions that address adrenal androgen production or improve overall metabolic health. Testing both testosterone and DHEA-S helps clarify which pathway is dominant.

Insulin resistance severity also differs. Some women with PCOS have normal insulin sensitivity and no acanthosis nigricans or skin tags. Their symptoms are driven almost entirely by androgen excess. Others have profound insulin resistance with minimal androgen elevation. The presence or absence of darkened skin and skin tags provides a clinical clue about which metabolic pathway is most disrupted. Measuring fasting insulin, glucose, and hemoglobin A1c quantifies this.

Turning symptoms into data and data into strategy

Skin and hair changes in PCOS aren't cosmetic annoyances. They're visible readouts of hormonal and metabolic dysfunction. Tracking the biomarkers that drive these symptoms reveals which pathways are most active and how they're changing over time:

  • Free testosterone and SHBG indicate androgen activity and how much testosterone is biologically available
  • DHEA-S distinguishes between ovarian and adrenal androgen sources
  • Insulin and glucose markers reveal the degree of insulin resistance driving metabolic symptoms

If androgen levels are high and insulin is normal, the priority is reducing androgen production or blocking androgen receptors. If insulin resistance is the dominant feature, improving insulin sensitivity through diet, exercise, and potentially medications like metformin becomes the focus. Often, both pathways are involved, and addressing one improves the other. Lowering insulin reduces ovarian androgen production. Reducing androgens can improve insulin sensitivity by decreasing visceral fat.

Monitoring changes in these markers over months shows whether interventions are working before symptoms fully resolve. Hair regrowth takes time. Acne improves in weeks to months. Acanthosis nigricans fades slowly as insulin sensitivity improves. But biomarkers shift faster, providing early feedback that you're moving in the right direction.

PCOS affects more than periods and fertility. It shows up on your face, your scalp, and your skin. Understanding the mechanisms behind these changes makes them less mysterious and more manageable. Superpower's 150+ biomarker panel tracks the hormones and metabolic markers that drive PCOS symptoms, so you can see exactly what's happening and adjust your approach based on data, not guesswork.

Frequently Asked Questions

References

  1. Amisi CA (2022). Markers of insulin resistance in Polycystic ovary syndrome women: An update. *World journal of diabetes*, *13*(3), 129-149. https://doi.org/10.4239/wjd.v13.i3.129
  2. Spiegel K, Tasali E, Penev P, Van Cauter E (2004). Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. *Annals of internal medicine*, *141*(11), 846-50. https://doi.org/10.7326/0003-4819-141-11-200412070-00008
  3. Nestler JE, Powers LP, Matt DW, Steingold KA, Plymate SR, Rittmaster RS, Clore JN, Blackard WG (1991). A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. *The Journal of Clinical Endocrinology and Metabolism*, *72*(1), 83-89. https://doi.org/10.1210/jcem-72-1-83
  4. Plymate SR, Matej LA, Jones RE, Friedl KE (1988). Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. *The Journal of Clinical Endocrinology and Metabolism*, *67*(3), 460-464. https://doi.org/10.1210/jcem-67-3-460
  5. Hermanns-Lê T, Scheen A, Piérard GE (2004). Acanthosis nigricans associated with insulin resistance: Pathophysiology and management. *American Journal of Clinical Dermatology*, *5*(3), 199-203. https://doi.org/10.2165/00128071-200405030-00008

Led by doctors with 40 years of health and longevity expertise

Dr. Anant Vinjamoori

Dr. Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Dr. Leigh Erin Connealy

Dr. Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Dr. Robert Lufkin

Dr. Robert Lufkin, MD

Physician & UCLA Medical School Professor, NYT bestselling author

Dr. Abe Malkin

Dr. Abe Malkin, MD

Founder & Medical Director of Concierge MD

Biological age 32 — a Superpower member portraitA health system built around you — test, understand, optimize150+ biomarkers across 2 blood drawsWhat to expect with Superpower — week 1 to month 3Trusted by 64,000+ customers — member reviewsBetter than the status quo — Superpower vs the old way60% of members found something a doctor missed — member survey
Daniel OSuperpower memberDavid LSuperpower memberRachel DSuperpower memberCamelia VSuperpower member

4.6 · 64,000+ members

Superpower health membership

Find early signs of 1,000+ conditions - then act, retest, and see what changed.

$349

/year*

150+ biomarkers annually across baseline + retest

Personalized plan that turns results into action

Superpower AI and on-demand care team

Results in 10 days or less

At-home or 2,000+ labs nationwide**

Yearly membership$0.96 / dayHSA/FSA eligible

*Pricing may vary for members in New York and New Jersey

**At-home labs for an additional cost

What we test

TestosteroneFree T4Vitamin DApoBHbA1cThyroid (TSH)hs-CRPFerritinCortisolFasting insulin

60%

found something a doctor missed

93%

rated it more useful than their checkup

77%

found something new in their results

Superpower member survey, 90 days post action plan (n=143).

How does the Superpower membership work?

We test 150+ biomarkers annually across two blood draws. Your baseline test paints a comprehensive picture of your health, and your dashboard shows what’s working, what needs attention, and what to do next. Superpower AI and your care team help you take action across lifestyle, supplements, and treatments. Then we retest to track your progress and continue refining your plan.

Can I cancel anytime?

Yes. You can cancel anytime, no fees. Your membership stays active through the end of your paid year.

How often should I test?

Your membership includes two blood tests per year: one to establish your baseline, and one to see whether your plan improved biomarkers that were out of range or not yet optimized. You can add other diagnostics anytime through the app or with help from your care team.

When will I get my results?

Book your draw at any of 2,000+ partner labs or at-home. Results are typically ready in about a week and land in the Superpower app.

What the 100+ panel measures

All 101 markers in your annual baseline draw, organized by system. Nothing here is an upsell.

Heart & Vascular Health

26

  • Apolipoprotein B
  • Atherogenic Coefficient
  • Atherogenic Index of Plasma
  • Castelli Risk Index I
  • Castelli Risk Index II
  • HDL Cholesterol
  • LDL Cholesterol
  • LDL/HDL Ratio
  • Cholesterol, Total
  • Non-HDL Cholesterol
  • Cholesterol/HDL Ratio
  • Carbon Dioxide, Total
  • High-sensitivity CRP
  • hsCRP-to-Albumin Ratio (CAR)
  • GGT-to-HDL Cholesterol Ratio
  • LDL-C to Apolipoprotein B Ratio (LDL-C/ApoB)
  • LDL Cholesterol / Total Cholesterol (Mass Ratio)
  • Monocyte-to-HDL Ratio (MHR)
  • Neutrophil-to-HDL Cholesterol Ratio (NHR)
  • Non-HDL Cholesterol-to-Apolipoprotein B Ratio (Non-HDL-C/ApoB)
  • NON-HDL Total Cholesterol Ratio
  • Triglyceride HDL Molar Ratio
  • Triglycerides
  • Triglyceride-to-Apolipoprotein B Ratio (TG/ApoB)
  • TyG Index
  • Uric Acid

Metabolic Health

4

  • Estim. Avg Glu (eAG)
  • Eag (mmol/l)
  • Glucose
  • Hemoglobin A1c

Energy

1

  • Cortisol

Liver Health

15

  • Albumin/Globulin Ratio
  • Albumin
  • Alkaline Phosphatase (ALP)
  • Alanine Aminotransferase (ALT)
  • Aspartate Aminotransferase (AST)
  • Bilirubin Direct
  • Bilirubin Indirect
  • Bilirubin, Total
  • Bilirubin-to-Albumin Ratio
  • Ferritin
  • Ferritin-to-Albumin Ratio
  • y-Glutamyl Transferase (GGT)
  • Globulin, Total
  • Indirect-to-Direct Bilirubin Ratio
  • Protein, Total

Kidney

11

  • Calcium
  • Chloride
  • Corrected Calcium (Albumin-adjusted)
  • Creatinine
  • Estimated Glomerular Filtration Rate (eGFR)
  • Potassium
  • Sodium
  • BUN/Creatinine Ratio
  • Blood Urea Nitrogen (BUN)
  • Urea-to-Creatinine Ratio
  • Uric Acid-to-HDL Cholesterol Ratio (UHR)

Sex Hormones

7

  • DHEA-Sulfate (DHEA-S)
  • Free Androgen Index
  • Sex Hormone Binding Globulin (SHBG)
  • Free Testosterone
  • Testosterone, Bioavailable
  • Testosterone, Total
  • Testosterone-to-Estradiol Ratio (T/E₂)

Thyroid Health

4

  • Free Thyroxine Index
  • T3 Uptake
  • T4 (thyroxine) Total
  • Thyroid-Stimulating Hormone (TSH)

Nutrients

13

  • Vitamin D
  • Red Cell Dist Width (RDW)
  • Hematocrit
  • Hemoglobin
  • Total Iron Binding Capacity (TIBC)
  • Iron
  • Iron Saturation
  • Mean Cell Hemoglobin (MCH)
  • Mean Corpuscular Hemoglobin Concentration (MCHC)
  • Mean Cell Volume (MCV)
  • Platelet-to-WBC Ratio (PWR)
  • Red Blood Cells
  • RDW MCV Ratio

Immune System

12

  • Basophils
  • Baso (Absolute)
  • Eosinophils
  • Eos (Absolute)
  • Lymphocytes
  • Lymphs (Absolute)
  • Monocytes
  • Monocytes (Absolute)
  • Neutrophils
  • Neutrophils (Absolute)
  • Mean Platelet Volume
  • Platelet Count

Inflammation

8

  • Lymphocyte-to-Monocyte Ratio (LMR)
  • Monocyte-to-Lymphocyte Ratio (MLR)
  • Neutrophil-to-Lymphocyte-Platelet Ratio (NLPR)
  • Neutrophil-to-Lymphocyte Ratio (NLR)
  • Platelet-to-Lymphocyte Ratio (PLR)
  • Systemic Immune-Inflammation Index
  • Systemic Inflammation Response Index (SIRI)
  • White Blood Cells
Get my health baseline

The full list of 100+ markers and 8 specialty add-ons available at superpower.com/biomarkers.